These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25956231)

  • 1. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.
    Lee MJ; Chen YF; Fan PC; Wang KC; Wang K; Wang J; Kuo MF
    J Neurol Sci; 2015; 353(1-2):161-5. PubMed ID: 25956231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213.
    Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R
    Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
    Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
    Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
    Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
    PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
    Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
    Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
    Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.